ISB News

ISB Announces Cynthia Shumate as Chief Legal Officer

ISB announces the appointment of Cynthia Shumate as the chief legal officer and chief compliance officer. She also will serve as the secretary of the ISB’s board of directors. Shumate’s has had a long career as the CLO or CCO of several biotechs, including including a number of notable private corporations including  ZetaRx Biosciences (now Juno Therapeutics) and Allozyne, as well as the public company PDL BioPharma. She is a member of the State Bar of Washington, the U.S. Patent Bar and is admitted to practice before the United States Supreme Court. As the CLO, Shumate will serve as a member of ISB’s Senior Leadership Team.




Recent Articles

  • Building a Better BMI

    ISB researchers have constructed biological body mass index (BMI) measures that offer a more accurate representation of metabolic health and are more varied, informative and actionable than the traditional, long-used BMI equation. The work was published in the journal Nature Medicine. 

  • How Immune Cells ‘See’ and Respond to Mutations in Cancer Cells

    In a just-published paper in the journal Nature, a collaborative team of researchers from ISB, UCLA, PACT Pharma, and beyond analyzed T-cell responses in melanoma patients who were treated with different immune checkpoint inhibitors, and how those responses evolved over time.

  • Spotlight on ISB Education graphic

    2022-23 School Year ISB Education Highlights

    From planning, creating and executing workshops for educators to forging new relationships to elevate students, the ISB Education team has been in high gear. Each month throughout the 2022-2023 academic year, we will highlight some of the top projects the team is working on.